NewAmsterdam Pharma (NASDAQ:NAMSW) Short Interest Down 80.0% in December

NewAmsterdam Pharma (NASDAQ:NAMSW) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 200 shares, a drop of 80.0% from the November 30th total of 1,000 shares. Based on an average daily volume of 6,700 shares, the days-to-cover ratio is currently 0.0 days.

NewAmsterdam Pharma Stock Performance

Shares of NAMSW stock traded down $0.21 during mid-day trading on Friday, reaching $14.47. 545 shares of the stock traded hands, compared to its average volume of 9,662. The stock’s fifty day simple moving average is $11.20 and its two-hundred day simple moving average is $9.06. NewAmsterdam Pharma has a 1-year low of $2.69 and a 1-year high of $16.75.

About NewAmsterdam Pharma

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.